In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

Lab services company Charles River Laboratories (NYSE:CRL) reported Q4 CY2024 results exceeding the market’s revenue ...

Many biotechnology companies can find it challenging to value the sales and marketing contributions made by their pharmaceutical partners, and yet they must be able to do so in order to negotiate ...

The heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for ...

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of ...

Biotechnology is a rapidly evolving sector with significant advancements anticipated between 2025 and 2035. As innovations in ...

Amidst a backdrop of volatile global markets, with U.S. stocks experiencing fluctuations driven by AI competition fears and mixed corporate earnings, investors are increasingly seeking stability ...

YTD Performance: 82.7% Sana Biotechnology (NASDAQ:SANA) is a company that makes medicine by engineering sales. Most of its ... efforts in order to extend their cash runway into 2026, and ...